DAILY HIVE: Vancouver-based magic mushrooms wellness company completes $20.7 million IPO

Vancouver-based company that focuses on health and wellness through pharmaceutical magic mushrooms has completed a $20.7 million initial public offering.

Optimi Health Corp is “developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness markets.”

The company says it also intends to cultivate, extract, process and distribute high-quality strains of fungi products at its proposed two facilities comprising a total of 20,000 square feet (presently under construction) located in Princeton, British Columbia.

Founded by four Vancouver-based entrepreneurs who have been friends since the early days of high school, the company’s advisory board includes lululemon founder Chip Wilson.

Optimi’s team includes Dane Stevens, co-founder of Vancouver’s leading boutique jewellery brand Cavalier, Bryan and Jacob Safarik, who own and operate BC Green, one of Canada’s leading premium cannabis producers, and J.J. Wilson, who is co-founder of Ride Cycle Club and a Partner at the Very Polite Agency.

“At its core, Optimi is positioned to be Canada’s first large-scale cultivator of natural, pharmaceutical-grade, psychedelic mushrooms (yes, magic mushrooms),” J.J. Wilson, Chairman of the Board, told Daily Hive.

“Upon licensing of our purpose-built facilities, we will be producing natural psilocybin mushrooms to support not only our own future products, but also to others in the industry requiring GMP product, as an alternative to the standard drugs we see today used to treat a variety of human conditions such as depression, anxiety, PTSD, and much more. The true power and opportunity of psilocybin is still being researched, but current data shows huge potential for positive impact in humans.”

Princeton facility/Courtesy of Optimi Health

Source: Vancouver-based magic mushrooms wellness company completes $20.7 million IPO | Venture (dailyhive.com)

Filed: Vancouver, Edmonton, Calgary, Toronto, Montreal

ABOUT OPTIMI

(CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FORWARD‐LOOKING STATEMENTS

Products do not contain psilocybin

Search
Get news & updates directly to your inbox.
Interested In Optimi? Let's Talk.